CDRH 2012 Strategic Priorities

FDA’s Center for Devices and Radiological Health (CDRH) recently released its 2012 Strategic Priorities, which includes a number of new initiatives and pilot programs designed to improve regulatory pathways and compliance processes as well as support new device-based...

Hope to Fill the VC Funding Gap for Early Stage Biotechs

Pearl Pathways serves the start up drug and device sector happily.  When we work with founders and the small management teams of start ups, it is some of the most rewarding work we do.  However, it’s no secret that early stage venture funding for biotechs has fallen...